Background: To evaluate the therapeutic strategies commonly employed in the clinic for the management of brain metastases (BMs) and to correlate disease outcome with type of treatment and therapeutic resources available at the treating center. Methods. Four Cancer centres participated to the survey. Data were collected through a questionnaire filled in by one physician for each centre. Results: Clinical data regarding 290 cancer patients with BMs from solid tumors were collected. Median age was 59 and 59% of patients had 3 brain metastases. A local approach (surgery and stereotactic radiosurgery) was adopted in 31% of patients. The local approach demonstrated to be superior in terms of survival compared to the regional/systemic approach (whole brain radiotherapy and chemotherapy, p = <.0001 for survival at 2 years). In the multivariate analysis local treatment was an independent prognostic factor for survival. When patients were divided into 2 groups whether they were treated in centers where local approaches were available or not (group A vs group B respectively, 58% of patients with 3 BMs in both cohorts), more patients in group A received local strategies although no difference in time to brain progression at 1 year was observed between the two groups of patients. Conclusions: In clinical practice, local strategies should be integrated in the management of brain metastases. Proper selection of patients who are candidate to local treatments is of crucial importance.

Brain metastases from solid tumors. Disease outcome according to type of treatment and therapeutic resources of the treating center / Fabi, A.; Felici, A.; Metro, G.; Mirri, A.; Bria, E.; Telera, S.; Moscetti, L.; Russillo, Michelangelo; Lanzetta, G.; Mansueto, G.; Pace, A.; Maschio, M.; Vidiri, A.; Sperduti, I.; Cognetti, F.; Carapella, CARMINE MARIA. - In: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. - ISSN 1756-9966. - 30:Jan 18(2011), pp. 1-7. [10.1186/1756-9966-30-10]

Brain metastases from solid tumors. Disease outcome according to type of treatment and therapeutic resources of the treating center

RUSSILLO, MICHELANGELO;Sperduti I.;Cognetti F.;CARAPELLA, CARMINE MARIA
2011

Abstract

Background: To evaluate the therapeutic strategies commonly employed in the clinic for the management of brain metastases (BMs) and to correlate disease outcome with type of treatment and therapeutic resources available at the treating center. Methods. Four Cancer centres participated to the survey. Data were collected through a questionnaire filled in by one physician for each centre. Results: Clinical data regarding 290 cancer patients with BMs from solid tumors were collected. Median age was 59 and 59% of patients had 3 brain metastases. A local approach (surgery and stereotactic radiosurgery) was adopted in 31% of patients. The local approach demonstrated to be superior in terms of survival compared to the regional/systemic approach (whole brain radiotherapy and chemotherapy, p = <.0001 for survival at 2 years). In the multivariate analysis local treatment was an independent prognostic factor for survival. When patients were divided into 2 groups whether they were treated in centers where local approaches were available or not (group A vs group B respectively, 58% of patients with 3 BMs in both cohorts), more patients in group A received local strategies although no difference in time to brain progression at 1 year was observed between the two groups of patients. Conclusions: In clinical practice, local strategies should be integrated in the management of brain metastases. Proper selection of patients who are candidate to local treatments is of crucial importance.
2011
adult; aged; aged, 80 and over; brain neoplasms; female; health care surveys; humans; kaplan-meier estimate; male; middle aged; multivariate analysis; treatment outcome; young adult; oncology service; hospital
01 Pubblicazione su rivista::01a Articolo in rivista
Brain metastases from solid tumors. Disease outcome according to type of treatment and therapeutic resources of the treating center / Fabi, A.; Felici, A.; Metro, G.; Mirri, A.; Bria, E.; Telera, S.; Moscetti, L.; Russillo, Michelangelo; Lanzetta, G.; Mansueto, G.; Pace, A.; Maschio, M.; Vidiri, A.; Sperduti, I.; Cognetti, F.; Carapella, CARMINE MARIA. - In: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. - ISSN 1756-9966. - 30:Jan 18(2011), pp. 1-7. [10.1186/1756-9966-30-10]
File allegati a questo prodotto
File Dimensione Formato  
Fabi_Brain-metastases_2011.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 296.54 kB
Formato Adobe PDF
296.54 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1310503
Citazioni
  • ???jsp.display-item.citation.pmc??? 23
  • Scopus 87
  • ???jsp.display-item.citation.isi??? 72
social impact